VOYA Investment Management
SNDX icon

VOYA Investment Management’s Syndax Pharmaceuticals SNDX Stock Holding History

VOYA Investment Management’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$806K Sell
36,874
-16,203
-31% -$337K ﹤0.01% 1611
2026
Q1 		$1.24M Sell
53,077
-505
-0.9% -$11K ﹤0.01% 1393
2025
Q4 		$1.13M Sell
53,582
-29,625
-36% -$517K ﹤0.01% 1442
2025
Q3 		$1.28M Sell
83,207
-7,648
-8% -$100K ﹤0.01% 1396
2025
Q2 		$851K Buy
90,855
+44,666
+97% +$492K ﹤0.01% 1642
2025
Q1 		$567K Sell
46,189
-2,642
-5% -$37.3K ﹤0.01% 1811
2024
Q4 		$646K Sell
48,831
-45,352
-48% -$776K ﹤0.01% 1829
2024
Q3 		$1.81M Sell
94,183
-89,466
-49% -$1.85M ﹤0.01% 1367
2024
Q2 		$3.77M Sell
183,649
-13,375
-7% -$280K ﹤0.01% 1116
2024
Q1 		$4.69M Buy
197,024
+30,991
+19% +$691K ﹤0.01% 1031
2023
Q4 		$3.59M Buy
166,033
+117,144
+240% +$1.8M ﹤0.01% 1130
2023
Q3 		$710K Sell
48,889
-81,729
-63% -$1.55M ﹤0.01% 1850
2023
Q2 		$2.73M Buy
130,618
+21,422
+20% +$446K ﹤0.01% 1231
2023
Q1 		$2.31M Buy
109,196
+14,683
+16% +$365K ﹤0.01% 1299
2022
Q4 		$2.41M Hold
94,513
– – ﹤0.01% 1257
2022
Q3 		$2.27M Buy
94,513
+75,293
+392% +$1.69M ﹤0.01% 1275
2022
Q2 		$370K Buy
19,220
+1,427
+8% +$23.8K ﹤0.01% 2028
2022
Q1 		$309K Hold
17,793
– – ﹤0.01% 2161
2021
Q4 		$389K Sell
17,793
-4
-0% -$74 ﹤0.01% 2161
2021
Q3 		$340K Sell
17,797
-155,289
-90% -$2.59M ﹤0.01% 2275
2021
Q2 		$2.97M Buy
173,086
+21,440
+14% +$393K 0.01% 1036
2021
Q1 		$3.39M Sell
151,646
-22,457
-13% -$507K 0.01% 977
2020
Q4 		$3.87M Buy
+174,103
New +$3.61M 0.01% 896
2020
Q2 		– Sell
-11,528
Closed -$126K – 2611
2020
Q1 		$126K Hold
11,528
– – ﹤0.01% 2287
2019
Q4 		$101K Buy
+11,528
New +$84.7K ﹤0.01% 2540

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

VOYA Investment Management's SNDX Position: Q2 2026 in Review

VOYA Investment Management reduced its Syndax Pharmaceuticals (SNDX) stake by 31% in Q2 2026, selling an estimated $337K and leaving 36,874 shares worth $806K. The position accounts for ﹤0.01% of the portfolio, ranked #1611.

VOYA Investment Management first reported a position in SNDX in Q4 2019 and has held it in 25 quarters since. The position peaked at $4.69M in Q1 2024. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • VOYA Investment Management held 36,874 shares of Syndax Pharmaceuticals worth $806K as of Q2 2026.
  • VOYA Investment Management sold 16,203 Syndax Pharmaceuticals shares in Q2 2026, an estimated $337K.
  • Syndax Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1611 holding.
  • VOYA Investment Management first reported a position in Syndax Pharmaceuticals in Q4 2019 and has held it in 25 quarters since.
  • VOYA Investment Management's Syndax Pharmaceuticals position peaked at $4.69M in Q1 2024.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.